TCON

TRACON Pharmaceuticals, Inc. Common Stock
TCON

Overview Fund Activity
Delisted

TCON was delisted on the 27th of June, 2024.

Back to rankings

20 hedge funds and large institutions have $46.3M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
1
Reduced
3
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$231K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$208K
3
CAM
3
ClariVest Asset Management
California
$176K
4
UBS Group
4
UBS Group
Switzerland
$71K
5
BJ
5
BlackRock Japan
Japan
$17K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
VAM
2
Visium Asset Management
New York
$4.94M
3
SIM
3
Spark Investment Management
New York
$0
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$0
5
OM
5
Opaleye Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
– -$31K -11 Closed
Citigroup
27
Citigroup
New York
– -$12K -4 Closed
PCM
28
Prelude Capital Management
New York
– -$1K -1 Closed
1
2